OCTAPHARMA AG

In News

Octapharma Plasma Notifies Individuals Affected by April 2024 Ransomware Attack - The HIPAA Journal

The HIPAA Journal - Sep 24, 2024

Rare Hematology Market to Grow by USD 4.58 Billion (2024-2028) as Strategic Portfolio Enhancements Drive Revenue; AI's Impact on Market Trends Report - Technavio - Yahoo Finance

Yahoo Finance - Nov 01, 2024

Dermatomyositis Market Predicted to See Upsurge Through 2034, - openPR.com

openPR.com - Jun 04, 2025

Octapharma to present clinical and scientific data that advances our understanding and treatment of bleeding disorders at the 17th Annual Congress of the European Association for Haemophilia and Allied Disorders (EAHAD), which takes place in Frankfurt, G - PR Newswire

PR Newswire - Jan 18, 2024

Takeover by the major shareholder - Noerr

Noerr - Sep 16, 2024

Octapharma Uses IVIG as Potential Treatment for COVID-19 - BioSpace

BioSpace - Aug 06, 2020

News | New Pay-for-Blood Plasma Business Coming to Providence - Elected Official Warns of “Exploitation” - GoLocalProv

GoLocalProv - Jul 17, 2024

Octapharma Plasma expanding U.S. HQ with $18.75M building acquisition - The Business Journals

The Business Journals - Feb 27, 2024

'Network issues' close Octapharma Plasma centers in Columbus and U.S. - The Columbus Dispatch

The Columbus Dispatch - Apr 19, 2024

Octapharma Plasma Forced to Close Locations Due to Cyberattack - CyberInsider

CyberInsider - Apr 19, 2024

Octapharma issues recall of one lot of its immune globulin Octagam - Fierce Pharma

Fierce Pharma - Apr 28, 2016

Blood money: Octapharma facility, offering cash for plasma, pops up in Brockton - Enterprise News

Enterprise News - Aug 11, 2020

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.